ArticleDiagnostics (Basel, Switzerland)2024
Optimized Hybrid Deep Learning Framework for Early Detection of Alzheimer's Disease Using Adaptive Weight Selection.
Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Explainable Patient-Level Cognitive Impairment Screening via Temporal, Semantic, and Psycholinguistic Multimodal AI.Journal of Intelligence · 2026Article
- Dynamic monitoring of public opinion on fertility intentions: based on the intersection of empirical and social media perspectives.Frontiers in public health · 2026Article
- Inductive and Transfer Learning-Based Hybrid Model Techniques for Accurate and Automated Diagnosis of Neurological Diseases.Brain and behavior · 2025Article
- Secure Hybrid Deep Learning for MRI-Based Brain Tumor Detection in Smart Medical IoT Systems.Diagnostics (Basel, Switzerland) · 2025Article
- Early Diagnosis of Alzheimer's Disease in Human Participants Using EEGConformer and Attention-Based LSTM During the Short Question Task.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAlzheimer's disease (AD) is a progressive neurological disorder that significantly affects middle-aged and elderly adults, leading to cognitive deterioration and hindering daily activities. Notwithstanding progress, conventional diagnostic techniques continue to be susceptible to inaccuracies and inefficiencies. Timely and precise diagnosis is essential for early intervention.
methodsWe present an enhanced hybrid deep learning framework that amalgamates the EfficientNetV2B3 with Inception-ResNetV2 models. The models were integrated using an adaptive weight selection process informed by the Cuckoo Search optimization algorithm. The procedure commences with the pre-processing of neuroimaging data to guarantee quality and uniformity. Features are subsequently retrieved from the neuroimaging data by utilizing the EfficientNetV2B3 and Inception-ResNetV2 models. The Cuckoo Search algorithm allocates weights to various models dynamically, contingent upon their efficacy in particular diagnostic tasks. The framework achieves balanced usage of the distinct characteristics of both models through the iterative optimization of the weight configuration. This method improves classification accuracy, especially for early-stage Alzheimer's disease. A thorough assessment was conducted on extensive neuroimaging datasets to verify the framework's efficacy.
resultsThe framework attained a Scott's Pi agreement score of 0.9907, indicating exceptional diagnostic accuracy and dependability, especially in identifying the early stages of Alzheimer's disease. The results show its superiority over current state-of-the-art techniques.
conclusionsThe results indicate the substantial potential of the proposed framework as a reliable and scalable instrument for the identification of Alzheimer's disease. This method effectively mitigates the shortcomings of conventional diagnostic techniques and current deep learning algorithms by utilizing the complementing capabilities of EfficientNetV2B3 and Inception-ResNetV2 by using an optimized weight selection mechanism. The adaptive characteristics of the Cuckoo Search optimization facilitate its application across many diagnostic circumstances, hence extending its utility to a wider array of neuroimaging datasets. The capacity to accurately identify early-stage Alzheimer's disease is essential for facilitating prompt therapies, which are crucial for decelerating disease development and enhancing patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.